
Medincell SA
PAR:MEDCL

Income Statement
Earnings Waterfall
Medincell SA
Revenue
|
10.7m
EUR
|
Cost of Revenue
|
-896k
EUR
|
Gross Profit
|
9.8m
EUR
|
Operating Expenses
|
-29.3m
EUR
|
Operating Income
|
-19.5m
EUR
|
Other Expenses
|
-11.9m
EUR
|
Net Income
|
-31.4m
EUR
|
Income Statement
Medincell SA
Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
1
N/A
|
3
+82%
|
3
+9%
|
2
-25%
|
8
+284%
|
9
+5%
|
4
-52%
|
9
+108%
|
10
+16%
|
11
+10%
|
9
-17%
|
11
+18%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(1)
|
|
Gross Profit |
0
N/A
|
1
+205%
|
2
+43%
|
1
-51%
|
7
+632%
|
7
+6%
|
3
-64%
|
7
+168%
|
6
-7%
|
7
+1%
|
7
+3%
|
10
+44%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(16)
|
(18)
|
(21)
|
(20)
|
(22)
|
(26)
|
(26)
|
(31)
|
(31)
|
(28)
|
(28)
|
(29)
|
|
Selling, General & Administrative |
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(11)
|
(11)
|
(12)
|
|
Research & Development |
(10)
|
(13)
|
(15)
|
(15)
|
(17)
|
(21)
|
(21)
|
(24)
|
(23)
|
(19)
|
(18)
|
(18)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Other Operating Expenses |
3
|
4
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
|
Operating Income |
(16)
N/A
|
(17)
-9%
|
(19)
-14%
|
(19)
0%
|
(16)
+20%
|
(19)
-20%
|
(24)
-28%
|
(24)
-2%
|
(24)
+1%
|
(21)
+11%
|
(21)
+2%
|
(20)
+6%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(4)
|
(2)
|
(2)
|
(4)
|
(3)
|
(1)
|
(1)
|
(2)
|
(8)
|
(5)
|
(4)
|
(12)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
Total Other Income |
(1)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Pre-Tax Income |
(20)
N/A
|
(19)
+5%
|
(21)
-14%
|
(23)
-8%
|
(19)
+18%
|
(20)
-5%
|
(25)
-24%
|
(27)
-8%
|
(32)
-19%
|
(26)
+17%
|
(25)
+6%
|
(31)
-25%
|
|
Net Income | |||||||||||||
Tax Provision |
0
|
(0)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(20)
|
(19)
|
(24)
|
(26)
|
(19)
|
(20)
|
(25)
|
(27)
|
(32)
|
(26)
|
(25)
|
(31)
|
|
Income to Minority Interest |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(20)
N/A
|
(19)
+4%
|
(24)
-27%
|
(26)
-7%
|
(19)
+26%
|
(20)
-5%
|
(25)
-24%
|
(27)
-8%
|
(32)
-19%
|
(26)
+17%
|
(25)
+5%
|
(31)
-26%
|
|
EPS (Diluted) |
-1.14
N/A
|
-0.94
+18%
|
-1.19
-27%
|
-1.2
-1%
|
-0.86
+28%
|
-0.8
+7%
|
-1
-25%
|
-1.07
-7%
|
-1.27
-19%
|
-0.94
+26%
|
-0.88
+6%
|
-1.08
-23%
|